Pay by Role
Indonesia · Salary comparison

Biomedical Engineer vs Civil Engineer salary

In Indonesia, a civil engineer earns about 12% more than a biomedical engineer $23,868 vs $21,309 per year.

Showing amounts in USD (USD default; source data is IDR). FX as of Mon, 13 Jul 2026 00:02:31 +0000. Convert currencies

Engineering
Biomedical Engineer
$21,309/yr
Monthly
$1,776
Hourly
$10
Range
$14,405$29,747
10-yr outlook
+7%
Pays more
Engineering
Civil Engineer
$23,868/yr
Monthly
$1,989
Hourly
$11
Range
$16,349$33,057
10-yr outlook
+8%

Pay range, side by side

PercentileBiomedical EngineerCivil Engineer
Entry (10th)$14,405$16,349
25th$17,857$20,109
Median$21,309$23,868
75th$25,528$28,462
Senior (90th)$29,747$33,057

National Indonesia figures in IDR. Individual pay varies with experience, employer, and location.

More Engineering comparisons

Frequently asked questions

Does a biomedical engineer or civil engineer earn more in Indonesia?
A civil engineer earns more, at about Rp 431.320.000 per year vs Rp 385.070.000 for a biomedical engineer — roughly 12% (Rp 46.250.000) more.
What is the salary range for these roles in Indonesia?
A biomedical engineer typically earns Rp 260.307.300–Rp 537.557.700, while a civil engineer earns Rp 295.454.200–Rp 597.378.200 per year.
How much do these jobs pay per month in Indonesia?
On a monthly basis before tax, a biomedical engineer averages about Rp 32.089.200 and a civil engineer about Rp 35.943.300.
How do entry-level salaries compare?
At the 10th percentile in Indonesia, a biomedical engineer earns about Rp 260.307.300 while a civil engineer earns about Rp 295.454.200 per year.
How do senior-level salaries compare?
At the 90th percentile in Indonesia, a biomedical engineer earns about Rp 537.557.700 while a civil engineer earns about Rp 597.378.200 per year.
Are biomedical engineer and civil engineer similar careers?
Both roles sit in the Engineering category on Pay by Role, which is why we compare them head-to-head. Day-to-day work still differs — review each job page for skills and outlook.